ArticleLung cancer (Amsterdam, Netherlands)2019

Outcomes of Stage III NSCLC with occult primary vs. known primary lesions.

Paul B Romesser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.